Business Description
Mentice AB
ISIN : SE0012673291
Total Employee Number:
129Compare
Compare
Traded in other countries / regions
MNTC.SwedenMN2.Germany IPO Date
2019-06-18Description
Mentice AB is a provider of software and hardware simulation solutions for image guided interventional therapies, offering proficiency based simulation solutions that help healthcare professionals acquire, retain, and enhance procedural skills, improving productivity and outcomes. Its solutions are scientifically validated and developed for healthcare providers and the medical device industry. Neurovascular, cardiovascular, and peripheral interventions are covered. Mentice operates in two segments: Medical Device Industry (MDI), providing end-to-end solutions supporting development and launch of interventional therapies, and Healthcare Systems (HCS). Product areas include Mentice VIST, Physical Sim, Mentice Live, and Ankyras. It operates in EMEA, APAC, and the Americas.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 3.64 | |||||
Equity-to-Asset | 0.41 | |||||
Debt-to-Equity | 0.13 | |||||
Debt-to-EBITDA | 1.08 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 1.51 | |||||
Beneish M-Score | -2.57 | |||||
WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 5.1 | |||||
3-Year EBITDA Growth Rate | 149.9 | |||||
3-Year EPS without NRI Growth Rate | 1.5 | |||||
3-Year Book Growth Rate | -7.8 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 10.08 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 55.51 | |||||
9-Day RSI | 50.17 | |||||
14-Day RSI | 47.8 | |||||
3-1 Month Momentum % | 14.18 | |||||
6-1 Month Momentum % | 14.18 | |||||
12-1 Month Momentum % | 1.57 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.99 | |||||
Quick Ratio | 0.89 | |||||
Cash Ratio | 0.33 | |||||
Days Inventory | 208.35 | |||||
Days Sales Outstanding | 94.22 | |||||
Days Payable | 97.84 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -2.8 | |||||
Shareholder Yield % | -1.91 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 88.75 | |||||
Operating Margin % | -6.07 | |||||
Net Margin % | -7.42 | |||||
EBITDA Margin % | 4.97 | |||||
FCF Margin % | -1.73 | |||||
OCF Margin % | 3.41 | |||||
ROE % | -17.81 | |||||
ROA % | -7.32 | |||||
ROIC % | -5.93 | |||||
3-Year ROIIC % | 26.22 | |||||
ROC (Joel Greenblatt) % | -58.09 | |||||
ROCE % | -12.1 | |||||
Years of Profitability over Past 10-Year | 2 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 137.22 | |||||
PS Ratio | 1.24 | |||||
PB Ratio | 2.98 | |||||
Price-to-Tangible-Book | 22.89 | |||||
Price-to-Operating-Cash-Flow | 41.43 | |||||
EV-to-EBIT | -20.84 | |||||
EV-to-Forward-EBIT | -326.28 | |||||
EV-to-EBITDA | 22.89 | |||||
EV-to-Forward-EBITDA | 13.6 | |||||
EV-to-Revenue | 1.14 | |||||
EV-to-Forward-Revenue | 1.07 | |||||
EV-to-FCF | -65.61 | |||||
Price-to-GF-Value | 0.5 | |||||
Price-to-Projected-FCF | 3.78 | |||||
Earnings Yield (Greenblatt) % | -4.8 | |||||
FCF Yield % | -1.35 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Mentice AB Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | 286.965 | ||
| EPS (TTM) (kr) | -0.822 | ||
| Beta | 0.4854 | ||
| 3-Year Sharpe Ratio | -0.4 | ||
| 3-Year Sortino Ratio | -0.58 | ||
| Volatility % | 67.5 | ||
| 14-Day RSI | 47.8 | ||
| 14-Day ATR (kr) | 0.571734 | ||
| 20-Day SMA (kr) | 12.9225 | ||
| 12-1 Month Momentum % | 1.57 | ||
| 52-Week Range (kr) | 8.5 - 18 | ||
| Shares Outstanding (Mil) | 28.13 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Mentice AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Mentice AB Stock Events
| Event | Date | Price (kr) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-11-10 | In 127 days | ||
| Third quarter earnings results for 2026 | 2026-11-10 | In 127 days | ||
| Second quarter earnings conference call for 2026 | 2026-07-23 | In 17 days | ||
| Second quarter earnings results for 2026 | 2026-07-23 | In 17 days | ||
| General meeting for 2026 | 2026-05-26 13:00 | 15.35 (-1.60%) | ||
| First quarter earnings conference call for 2026 | 2026-05-07 | 12.95 (-0.77%) | ||
| First quarter earnings results for 2026 | 2026-05-07 | 12.95 (-0.77%) | ||
| Annual report for 2025 | 2026-04-23 | 12.95 (+0.00%) | ||
| Fourth quarter earnings conference call for 2025 | 2026-02-26 10:00 | 14.00 (+1.08%) | ||
| Fourth quarter earnings results for 2025 | 2026-02-26 | 14.00 (+1.08%) |
Show
Entries
Mentice AB Frequently Asked Questions
What is Mentice AB(OSTO:MNTC)'s stock price today?
The current price of OSTO:MNTC is kr13.05. The 52 week high of OSTO:MNTC is kr18.00 and 52 week low is kr8.50.
When is next earnings date of Mentice AB(OSTO:MNTC)?
The next earnings date of Mentice AB(OSTO:MNTC) is 2026-07-23.
Does Mentice AB(OSTO:MNTC) pay dividends? If so, how much?
Mentice AB(OSTO:MNTC) does not pay dividend.
Press Release
Articles on Mentice AB
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers